🎉Really happy to share our first original research article, ahead of our inaugural issue of the journal. @guilhermepovala.bsky.social & colleagues from the HEAD study propose a PET–CT pipeline using low-dose CT to quantify tau PET without MRI. Read #openaccess bit.ly/45KxZUg #Alzheimers #MRI #PET

📣 The Lancet #MedicalImaging & #Theranostics is now indexed in Crossref.  We are committed to supporting you on every stage of your publication journey. Learn more about our scope, impact, and global reach: hubs.li/Q04k_6ym0 #OpenAccess #MedSky

🆕Our July issue is live! 📊Articles: #NSCLC #Breastcancer #prostatecancer #glioblastoma 📉Trials: AENEAS2, SUBITO, EORTC 22922/10925, ARTO, PRIMARY2, CAIRO6, & INTRAGO-II 🎨Cover: Meta-analysis on AEs of CD3 T cell-engaging bispecific abs Read here: thelancet.com/issue/S1470-...

Attending #RCRGlobalAI in London? Our team, Ali Landman and Ankita Das will be there and available to discuss about our journal, your projects and potential collaborations! Feel free to reach out

💥 Introducing The Lancet Medical Imaging & Theranostics podcast 💥 🎙️ In our debut episode, our Editor-in-Chief is joined by Dr Preusser and @nathaliealbert.bsky.social to discuss insights from the @nmnsymposium.bsky.social. 🎧 Listen to the episode bit.ly/49F56LM

Hope you are enjoying #SNMMI2026 and/or #ASCO2026! Feel free to reach out directly to discuss potential submissions!

📣 Just in time for #ASCO2026 & #SNMMI2026... Read a new Comment from Keamogetswe Ramonaheng and Mike Sathekge at NuMeRI on the crucial role of dosimetry in delivering truly personalised treatments in oncology Read for free: www.thelancet.com/journals/lan...

Dosimetry as the compass of radiotheranostics: from fixed activity to true precision

Radiopharmaceutical therapy stands at a decisive crossroads. After decades of administering mostly fixed or weight-based activities (the amount of radioactivity administered to a patient),1,2 the scie...

thelancet.com

Heading to #ASCO26? Reach out to Dr David Collingridge, Editor-in-Chief at @thelancetoncol.bsky.social, attending #ASCO26 🗓️ Attend the Global Oncology: A Workforce Crisis—A Lancet Oncology Commission session May 31, 2026, 4:30 PM-5:45 PM CDT #cancerworkforce meetings.asco.org/meetings/202...

Our deputy editor, Pierre Nauleau, will attend #AIUM the #Ultrasound conference in Philadelphia later this week. Please reach out if you want to meet and discuss your research! @aiumultrasound.bsky.social

🆕 Greater transparency for oncology clinical trials reporting Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials Read here: thelancet.com/journals/lan...

Hope you are enjoying the presentations at #ISMRM2026. Feel free to reach out if you would like to discuss potential submissions to the journal with the editorial team!

🎉Proud to share our first online article by @nathaliealbert.bsky.social & colleagues that was presented at #NMN2026 @nmnsymposium.bsky.social www.thelancet.com/action/showF...

Imaging-based classification of blood–brain barrier disruption in glioblastoma for patient selection in clinical trials: the NMN-BBB score

The blood–brain barrier (BBB) limits the activity of novel treatments, such as pharmacotherapies and targeted radionuclide therapies in glioblastoma. Selection of patients with extensive tumoural BBB ...

thelancet.com

📌In case you missed it📌 You can watch our webinar on Publishing Excellence with The Lancet Medical Imaging & Theranostics on demand now ➡️ hubs.li/Q042sbkM0 Many thanks to all who attended live and provided us with some great discussion points

Our editor in chief, Ali Landman, will attend @nmnsymposium.bsky.social in Vienna, May 7-8. Please reach out if you would like to discuss about our new journal, your research and potential collaborations! #NMN2026

📅 This time next week, please join us for our webinar on Publishing Excellence with The Lancet Medical Imaging & Theranostics Register here to attend live or to receive a link to the recording ➡️ hubs.li/Q042sbn40

📢 Join our webinar on publishing excellence on April 30, 2026, 15.00 BST/10.00 EDT Register to attend live or receive the link to the on-demand version when available ➡️https://hubs.li/Q042sbn40

Retroperitoneal fibrosis is a rare immune-mediated disease which can be classified as idiopathic or secondary. A new Seminar provides an overview of retroperitoneal fibrosis focusing on pathophysiology, differential diagnosis, and management: spkl.io/63323AFbdz

📢 Have you registered yet? Register now: hubs.li/Q042sbn40 Join our editorial team as we share insights on their journal's aims and scope, what we look for in a research paper, and best practices for preparing your manuscript. #MedSky #RadSky

🔎 Want to learn more about the journal's aims and scope and what we are looking for in a research paper? 🎬 Join us on April 30th for a webinar on publishing excellence with The Lancet Medical Imaging & Theranostics For more information and to register see ➡️ hubs.li/Q042sbn40

💡 Stay connected to your field. Access our late-breaking content, Series and Commissions, and learn about our involvement at global conferences. Register for Lancet Conference Alerts today: hubs.li/Q045K7ZC0 #Radiology #MedicalImaging #Radsky

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean. Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw #medsky

This month's podcast: James Nagarajah on [177Lu]-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study 🎧 Listen & subscribe! Spotify: open.spotify.com/show/3JOj0Cl... Apple: podcasts.apple.com/us/podcast/t...

The Lancet Oncology@thelancetoncol.bsky.social · 4mo ago

🆕Our April issue is live! 📊Articles: #NSCLC, #bladdercancer, #melanoma, #prostatecancer, #breastcancer 📰Reviews: A PSOGI–ESGO–ISSPP Lyon consensus & OPTIMISE-AR recommendations for visualising PROs Cover: Spaceflight as a cancer research catalyst www.thelancet.com/issue/S1470-...

Have you signed up for alerts from The Lancet Medical Imaging & Theranostics yet?   Register for Table of Contents & Online First Alerts, sent monthly from when our first issue is available, or weekly for Online First content. Sign up to Journal Alerts here hubs.li/Q045JY-R0 #goldopenaccess

🎧NEW podcast Our editor-in-chief, Ali Landman talked with Cheryl Lai, deputy editor of @thelancetoncol.bsky.social about our journal, its scope, the team. She also shared her takeaways from the European Congress of Radiology #ECR. #RadSky

Ali Landman on the European Congress of Radiology 2026 - The Lancet Oncology in conversation with

Join us for this special episode where Deputy Editor Cheryl Lai speaks with Ali Landman, Editor-in-Chief of The Lancet Medical Imaging & Theranostics, about the scope and vision of the new journal...

buzzsprout.com

Our new issue is out now 🎉 We feature research on #bladdercancer, routine testing for detection of #syphilis, and point-of-care testing strategies for #antibioticprescribing for respiratory tract infections, and more! Explore and download the issue on our journal homepage: hubs.li/Q03yqV6c0.

Thinking where to submit your next manuscript? We’re inviting quality, original research in clinical and technological advances in #radiology, nuclear medicine and theranostics. APCs will be waived on accepted Articles submitted by Sep 2, 2026. Learn more: hubs.li/Q045K3jl0 #goldopenaccess

This Monday is the 26th Annual @roysocmed.bsky.social #PET day. Our editor in chief, Ali Landman, and our senior editor, Ankita Das will be there. Please reach out if you want to discuss about the journal, your research and potential collaborations! www.rsm.ac.uk/events/radio...

26th Annual RSM PET day

Explore the role of emerging tracers, the impact of artificial intelligence on PET and gain a better understanding of PET-CT in common malignancies.

nam11.safelinks.protection.outlook.com

Our March issue is now online: www.thelancet.com/journals/lan... Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #malaria #HIV #Streptococcus #PCV #RiftValleyFever #pertussis #tuberculosis #TB #AMR #IDSky #ClinMicro #TBSky #OA

📅 Save the date 📅 Join our editorial team on Thursday April 30th for a webinar on publishing excellence with The Lancet Medical Imaging and Theranostics, a new open access journal within the Lancet group. 👉Register to attend hubs.li/Q042sbn40 🗓️ Thurs, April 30, 2026 🕒15:00 BST / 10:00 EDT

Our editor in chief, Ali Landman, is still attending #ECR2026. Feel free to reach out if you would like to discuss the journal or your research! www.linkedin.com/feed/update/...

| The Lancet Medical Imaging & Theranostics

Sign in or join now to see posts like this one and more.

linkedin.com